| Reversing a model of Parkinson’s disease with in situ converted nigral neurons H Qian, X Kang, J Hu, D Zhang, Z Liang, F Meng, X Zhang, Y Xue, ... Nature 582 (7813), 550-556, 2020 | 381 | 2020 |
| SRPKIN-1: a covalent SRPK1/2 inhibitor that potently converts VEGF from pro-angiogenic to anti-angiogenic isoform JM Hatcher, G Wu, C Zeng, J Zhu, F Meng, S Patel, W Wang, SB Ficarro, ... Cell chemical biology 25 (4), 460-470. e6, 2018 | 118 | 2018 |
| Initiation of parental genome reprogramming in fertilized oocyte by splicing kinase SRPK1-catalyzed protamine phosphorylation LT Gou, DH Lim, W Ma, BE Aubol, Y Hao, X Wang, J Zhao, Z Liang, ... Cell 180 (6), 1212-1227. e14, 2020 | 67 | 2020 |
| Biochemical characterization and zinc binding group (ZBGs) inhibition studies on the catalytic domain of MMP7 (cdMMP7) F Meng, H Yang, C Jack, H Zhang, A Moller, D Spivey, RC Page, ... Journal of Inorganic Biochemistry 165, 7-17, 2016 | 6 | 2016 |
| Base excision repair pathway regulates transcription-replication conflicts in pancreatic ductal adenocarcinoma F Meng, AK Singh, T Li, M Attiyeh, F Kohram, T Williams, Y Liu, M Raoof bioRxiv, 2023.10. 03.560510, 2023 | 1 | 2023 |
| Biochemical and spectroscopic characterization of the catalytic domain of MMP16 (cdMMP16) F Meng, H Yang, M Aitha, S George, DL Tierney, MW Crowder JBIC Journal of Biological Inorganic Chemistry 21, 523-535, 2016 | 1 | 2016 |
| Abstract C065: Base excision repair pathway regulates transcription-replication conflicts in pancreatic ductal adenocarcinoma F Meng, AK Singh, T Li, M Attiyeh, F Kohram, T Williams, Y Liu, M Raoof Cancer Research 84 (2_Supplement), C065-C065, 2024 | | 2024 |
| Integrated characterization of cell types, states and molecular programs in disseminated appendiceal neoplasms LT Bui, X Cao, JT Wang, F Meng, M Feng, L Arvanitis, R Mannan, Y Woo, ... bioRxiv, 2023.09. 28.559817, 2023 | | 2023 |
| Therapeutic Targeting of Oncogene-induced Transcription-Replication Conflicts in Pancreatic Ductal Adenocarcinoma SJ Smith, F Meng, R Lingeman, C Li, M Li, G Boneh, TT Seppälä, T Phan, ... medRxiv, 2023.10. 03.23296487, 2023 | | 2023 |
| Pan-cancer analysis of promoter or promoter-proximal somatic mutations defines transcription-replication conflict mutational signature MA Attiyeh, F Meng, Y Liu, N Banovich, M Raoof Cancer Research 82 (12_Supplement), 6342-6342, 2022 | | 2022 |
| YIA22-006: Characterization of Transcription-Replication Conflicts in KRAS-driven Pancreatic Cancer F Meng, Y Liu, M Raoof Journal of the National Comprehensive Cancer Network 20 (3.5), YIA22-006 …, 2022 | | 2022 |
Zhengyu LiangUCSD在 ucsd.edu 的电子邮件经过验证
